Meet John Papadopoulos, M.D.
John N. Papadopoulos, M.D.
Department of Urology, Division of Surgery
Present Title & Affiliation
Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
|2002||Texas Tech University School of Medicine, Lubbock, TX, USA, MD, Medicine|
|1997||University of Texas, Austin, TX, USA, BA, Business Administration in Finance|
|2007-2009||Clinical Fellowship, Urology Oncology, University of Texas MD Anderson Cancer Center, Houston, TX|
|2007-2008||Research Fellowship, Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX|
|2004-2007||Clinical Residency, General, University of Wisconsin Hospital and Clinics, Madison, WI|
|2003-2004||Clinical Internship, General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI|
|2011||American Board of Urology|
Experience & Service
Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018
- Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 118(1):68-76, 2016. e-Pub 2015. PMID: 26059275.
- Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol 174(5):1972-80, 2009. e-Pub 2009. PMID: 19349357.
- Kaplon D, Jarrard DF, Papadopoulos JN. Urothelial Tumors of the Renal Pelvis and Ureters. eMedicine, 2009.
- Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol 181(1):81-7; discussion 87, 2009. e-Pub 2008. PMID: 19012911.
- Shaw A, Papadopoulos J, Johnson C, Bushman W. Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. Prostate 66(13):1347-58, 2006. PMID: 16752376.